MadeMed Review
Doctor-backed compounded telehealth across GLP-1, peptides, NAD+, and sexual health, with oral alternatives to injections.
Reader-supported, we may earn a commission through links on this site. Rankings are editorially independent. Disclosure · Methodology
Quick Verdict
Doctor-backed compounded telehealth across GLP-1, peptides, NAD+, and sexual health, with oral alternatives to injections.
Who it's for: MadeMed fits readers who want a single clinic for compounded GLP-1 plus longevity peptides like NAD+ and sermorelin, and who appreciate having an oral route as a needle-free alternative. Less suited if you specifically need brand-name FDA-approved GLP-1.
Bottom line: A solid compounded-only generalist with one of the lowest entry prices for oral semaglutide. The NAD+ and sermorelin menu is a real differentiator for longevity-curious buyers.
- Low $99/mo entry price for oral semaglutide
- Both injectable and oral routes for GLP-1
- Wide peptide and NAD+ menu beyond pure weight loss
- Compounded only — no brand-name Wegovy, Zepbound, Ozempic, or Mounjaro
- NAD+ and oral GLP-1 absorption are less clinically validated than injection
Pros & Cons In Detail
MadeMed Pricing
Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at MadeMed.
| Program / Membership Fee | Included in monthly plan |
| Medication Cost (From) | From $99 – $349/mo |
MadeMed prices each protocol as a flat monthly fee that includes medication, board-certified physician consultation, and discreet shipping. Prices range from $99/mo for oral semaglutide up to $269/mo for NAD+ nasal spray.
Who MadeMed Is For
MadeMed fits readers who want a single clinic for compounded GLP-1 plus longevity peptides like NAD+ and sermorelin, and who appreciate having an oral route as a needle-free alternative. Less suited if you specifically need brand-name FDA-approved GLP-1.
Adults who want doctor-backed compounded GLP-1, peptide, and sexual-health protocols with both injectable and oral routes.
Signature Programs
- ›Oral and injectable semaglutide
- ›Oral and injectable tirzepatide
- ›NAD+ injectable & nasal spray
- ›Sermorelin peptide protocols
Medication Formulary
The Bottom Line
A solid compounded-only generalist with one of the lowest entry prices for oral semaglutide. The NAD+ and sermorelin menu is a real differentiator for longevity-curious buyers.
With an editor score of 4.3 / 5 across cost, experience, and trust, MadeMed is one of the strong mid-tier options in the glp-1 weight loss category we cover.
See how MadeMed compares in our full glp-1 weight loss rankings, or read the Best Compounded GLP-1 Telehealth Providers guide. Our methodology explains how we score each provider.
Frequently Asked Questions
- Wilding et al., NEJM 2021 (STEP 1) · Semaglutide 2.4 mg produced 14.9% mean weight loss vs 2.4% placebo at 68 weeks in the STEP 1 trial.
- FDA Federal Register 2024 (Semaglutide shortage end) · FDA removed semaglutide from the drug shortage list in October 2024, ending the legal basis for compounding.
- Jastreboff et al., NEJM 2022 (SURMOUNT-1) · Tirzepatide 15 mg produced 20.9% mean weight loss vs 3.1% placebo at 72 weeks in SURMOUNT-1.
- FDA Federal Register 2024 (Tirzepatide shortage end) · FDA removed tirzepatide from the drug shortage list in October 2024.
RxNotebook is an editorial publication. Citations point to peer-reviewed journals, FDA labeling, and clinical society guidelines. We are not affiliated with the studies cited above. This page is for general information and is not medical advice.
